Change of estrogen receptor, progesterone receptor, and Ki67 after neoadjuvant chemotherapy in patients with locally advanced breast cancer - Egyptian Knowledge Bank - troweb

221719

Change of estrogen receptor, progesterone receptor, and Ki67 after neoadjuvant chemotherapy in patients with locally advanced breast cancer

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

The Effect of Hormone Receptor Status on Pathological Response after Preoperative Therapy in Breast Cancer Patients

Article

Immunohistochemical study of GATA3 and Androgen receptors in breast cancer

Article

Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer

Article

Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer

Article

Role of Some Estrogen Receptor and Her2 Pathway related Genes (PIK3CA, GSK3 β) in Predicting Response to Tamoxifen in Breast Cancer Patients

Article

Estrogen Receptor Signaling in Breast Cancer

Article

Correlation between Strength of Estrogen Receptor positivity and Outcome of Adjuvant Tamoxifen Therapy in Breast Cancer Patients

Article

CORRELATON BETWEEN OESTROGEN RECEPTORS AND HISTO- PATHOLOGICAL PARAM‌ETERS IN HUMAN BREAST CANCER

Article

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

Article

The Effect of Neoadjuvant Chemotherapy on Her-2 Status in Her-2 Negative Breast Cancer Patients: A Study on Pathological Response